Tag: Covid

Categories
Health

Which Covid Vaccine Ought to You Get? Specialists Weigh the Impact Towards Extreme Illness

Which Covid Vaccine Should You Get? Experts Weigh the Effect Against Severe Disease

At first glance, the results reported on Friday of the long-awaited study of Johnson & Johnson’s coronavirus vaccine may have been disappointing. Overall effectiveness – the ability to prevent moderate and severe illnesses – was reported at 72 percent in the United States, 66 percent in Latin American countries, and 57 percent in South Africa.

These numbers are well below the high bar set by Pfizer-BioNTech and Moderna, the first two emergency vaccines approved in the United States, which had an overall effectiveness of 94 to 95 percent.

Dr. Anthony S. Fauci, the nation’s leading infectious disease expert and now President Biden’s leading medical advisor on the coronavirus pandemic, acknowledged the remarkable difference at a briefing Friday.

“If you woke up and say, ‘Well, go to the left door and you get 94 or 95 percent, go to the right door and you get 72 percent. ‘Which door do you want to go to? ”He asked.

Dr. However, Fauci said the most important measure is the ability to prevent serious illness, which means keeping people out of the hospital and preventing deaths. For Johnson & Johnson, that result was 85 percent in all of the countries it was tested in, including South Africa, where a rapidly spreading variant of the virus had shown some ability to evade vaccines.

More important than preventing “some pain and a sore throat,” said Dr. Fauci, is the defense against serious illnesses, especially in people with underlying diseases and in older adults who are more likely to become seriously ill and die of Covid. 19th

“If you can prevent serious illness in a high percentage of people, it will soothe the stress of human suffering and death in this epidemic that we are seeing it right now,” said Dr. Fauci, “As we know, over the past few weeks our healthcare system has been burdened by the number of people requiring hospitalization and intensive care.”

Dr. Francis Collins, director of the National Institutes of Health, compared the ability to prevent serious illness to the effects of flu vaccinations, which may not always prevent influenza completely, but make it less severe.

“The same seems to be true here, in circumstances where this variant clearly makes it a little harder to get the most forceful response you want,” said Dr. Collins. “But it still looks very good for serious illnesses.”

The Moderna vaccine also showed high 100 percent effectiveness against serious illnesses. The Pfizer BioNTech appeared to be too, but the total number of severe cases in the study was too few to be certain.

However, the researchers caution that trying to compare effectiveness between new and previous studies can be misleading because the virus is developing quickly and the studies have to some extent examined different pathogens.

“You have to realize that Pfizer and Moderna had an advantage,” said Dr. William Schaffner, an infectious disease expert at Vanderbilt University, in an interview. “They did their clinical studies before the variant strains became very clear. Johnson & Johnson not only tested their vaccine against the standard strain, but they also had the variants. “

The best way to stop the spread of mutants and prevent new ones from emerging is to vaccinate as many people as you can as soon as possible, says Dr. Fauci and other researchers. Viruses can’t mutate if they can’t replicate, and they can’t replicate if they can’t get into cells. Keeping them away from people by immunizing them can kill the process.

In addition to the Pfizer BioNTech and Moderna vaccines already in use in the US, three more may soon be available: those made by Novavax, Johnson & Johnson and AstraZeneca. AstraZeneca’s vaccine has already been approved in the UK and other countries.

Globally, the Johnson & Johnson vaccine is expected to play an important role, especially in low- and middle-income countries, as it works after just one shot, is relatively inexpensive, and is easier to store and distribute than Pfizer-BioNTech’s manufactured vaccines and Moderna, as it does not share their strict requirements for freezing and chilling.

People waiting to be vaccinated may wonder if they will be able to choose vaccines and if they should hold out and wait until the one that looks best to them becomes available.

Covid19 vaccinations>

Answers to your vaccine questions

Am I eligible for the Covid vaccine in my state?

Currently more than 150 million people – almost half of the population – can be vaccinated. But each state makes the final decision on who goes first. The country’s 21 million healthcare workers and three million long-term care residents were the first to qualify. In mid-January, federal officials asked all states to open eligibility to anyone over the age of 65 and adults of any age with medical conditions that are at high risk of becoming seriously ill or dying of Covid-19. Adults in the general population are at the end of the line. If federal and state health authorities can remove bottlenecks in the distribution of vaccines, everyone over the age of 16 is eligible as early as spring or early summer. The vaccine has not been approved in children, although studies are ongoing. It can take months before a vaccine is available to anyone under the age of 16. For the latest information on vaccination guidelines in your area, see your state health website

Is the Vaccine Free?

You shouldn’t have to pay anything out of pocket to get the vaccine, despite being asked for insurance information. If you don’t have insurance, you should still get the vaccine for free. Congress passed law this spring banning insurers from applying cost-sharing such as a co-payment or deductible. It consisted of additional safeguards prohibiting pharmacies, doctors, and hospitals from charging patients, including uninsured patients. Even so, health experts fear that patients will end up in loopholes that make them prone to surprise bills. This could be the case for people who are charged a doctor’s visit fee with their vaccine or for Americans who have certain types of health insurance that are not covered by the new regulations. If you received your vaccine from a doctor’s office or emergency clinic, talk to them about possible hidden costs. To make sure you don’t get a surprise invoice, it is best to get your vaccine at a Department of Health vaccination center or local pharmacy as soon as the shots become more widely available.

Can I choose which vaccine to get?How long does the vaccine last? Do I need another next year?

That is to be determined. It is possible that Covid-19 vaccinations will become an annual event just like the flu vaccination. Or the vaccine may last longer than a year. We’ll have to wait and see how durable the protection from the vaccines is. To determine this, researchers will track down vaccinated people to look for “breakthrough cases” – those people who get Covid-19 despite being vaccinated. This is a sign of a weakening of protection and gives researchers an indication of how long the vaccine will last. They will also monitor the levels of antibodies and T cells in the blood of people who have been vaccinated to see if and when a booster shot might be needed. It is conceivable that people might need boosters every few months, once a year, or just every few years. It’s just a matter of waiting for the data.

Does my employer need vaccinations?Where can I find out more?

Dr. Paul Offit, a vaccines expert at Philadelphia Children’s Hospital, told CNN that Pfizer-BioNTech and Moderna vaccines would be his first choice when they were abundant because of their higher overall effectiveness.

But right now there aren’t enough of these vaccines.

If he couldn’t get the Pfizer BioNTech vaccine or the Moderna vaccine, he would do the Johnson & Johnson shot, said Dr. Offit – as long as the data the company will submit to the Food and Drug Administration looks as good as the company reported on Friday.

He said Johnson & Johnson’s Serious Disease Reduction Report was a strong selling point.

“That’s what you want,” said Dr. Offit. “You want to stay out of the hospital and out of the morgue.”

He noted that the company was also investigating a two-shot regimen that could increase its effectiveness.

People taking the Johnson & Johnson vaccine should be able to safely get a Pfizer BioNTech or Moderna vaccine later if a booster shot is needed, he said.

Dr. Schaffner said he had just attended a meeting with other public health experts and they asked each other what they would say to their spouses or partners if they could get the Johnson & Johnson vaccine tomorrow or had to wait three weeks Pfizer- BioNTech’s or Moderna’s.

“We all said, ‘Get it tomorrow,” said Dr. Schaffner. “The virus is bad. You risk another three weeks of exposure instead of receiving protection tomorrow.”

He said the 85 percent effectiveness of Johnson & Johnson against serious illnesses is a little less than that reported by Moderna and Pfizer-BioNTech, “but it’s still damn high.”

It is not yet known whether it is safe to take a different type of vaccine every now and then, said Dr. Schaffner, adding, “We haven’t investigated this.”

Categories
Health

There can be sufficient Covid vaccines for the ‘complete U.S. grownup inhabitants by June,’ physician says

J&J plans to have 100 million vaccines for Americans by spring, board member says

Dr. Johnson & Johnson board member Mark McClellan told CNBC Friday that there could be enough vaccinations for the entire US adult population by the summer.

“Assuming that accurate verification of the J&J data is no longer possible, we will have the capacity between Moderna, Pfizer and J&J to have enough vaccines available for the entire US adult population by June “said McClellan, a former FDA commissioner, said on” The News with Shepard Smith. ”

The US plans to buy 200 million doses of Covid vaccine from Moderna and Pfizer. The Department of Health and Human Services will increase its vaccine supply to states from 8.6 million to at least 10 million doses per week. To date, states have received more than 49 million doses, but only about half of those actually landed in people’s arms, according to the Centers for Disease Control and Prevention. The agency reports that the US fires just over a million shots every day.

McClellan that the US should significantly increase the number of shots given per day and “should bring our ability to vaccinate closer to 3 million doses per day.”

The US has ordered 100 million doses of the J&J vaccine, which the company plans to deliver by June. J&J plans to apply for an emergency permit next week. If J & J’s vaccine is FDA approved, it will be the third emergency approved vaccine in the U.S. Pfizer’s vaccine was approved by the FDA on December 11th, and Moderna’s was approved a week later.

The efficacy numbers for J&J vaccines were lower than for Pfizer and Moderna. Pfizer’s vaccine was found to be 95% effective against Covid-19, while Moderna’s vaccine was about 94% effective. J & J’s vaccine was found to be 66% overall effective in preventing moderate to severe Covid.

Host Shepard Smith asked McClellan about the lower efficacy numbers compared to Pfizer and Moderna, explaining to Smith, “We are fighting a different virus today than three months ago when previous studies were done.”

In addition, J&J conducted its test on three continents, and the level of protection varied depending on the region. The vaccine showed an overall effectiveness of 72% in the US and 66% in Latin America. In South Africa, where the dangerous B.1.351 strain of Covid caused spikes in some cases, the J&J vaccine showed 57% effectiveness.

“Unfortunately, in three months’ time, we’ll likely be fighting another virus. The most important thing to winning this fight is getting as many people as possible vaccinated,” said McClellan. “The faster we shoot in the arms, the more people will be vaccinated here in this country and around the world, the better we can contain this further spread and further damage from Covid.”

Categories
Business

Moderna asks FDA to authorize 5 further doses per Covid vaccine vial to hurry distribution, supply tells CNBC

Moderna asks FDA to authorize 5 additional doses per Covid vaccine vial to speed distribution, source tells CNBC

A health care worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination station operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in New York on January 29, 2021 .

Facebook Facebook Logo Log in to Facebook to connect with Mike Segar Reuters

Moderna has asked the U.S. Food and Drug Administration for permission to fill their Covid-19 vaccine bottles with up to five additional doses to help clear a manufacturing bottleneck, according to a person familiar with the matter.

The change would allow Moderna to fill 15 cans into vials of the same size, now cleared for 10, which eases the pressure on the manufacturing process known as filling / finishing, said the person who refused to named because the application is not public yet.

The availability of Covid-19 vaccines has caused frustration since their approval in the US in mid-December. While the pace of administration has increased to an average of more than 1 million a day, the limited supply has hampered states’ ability to operate mass vaccination centers. By Friday, the US had distributed 49.2 million doses and 27.9 million had been given, according to the Centers for Disease Control and Prevention.

“We have problems making these mRNA vaccines,” said Dr. Paul Offit, director of the Vaccine Education Center and a physician at Philadelphia Children’s Hospital. “We have up to 1.2 million doses a day when we need 3 million doses a day.”

The FDA declined to comment and asked questions to the company. Moderna did not immediately respond to a request for comment.

The move from Moderna came after Pfizer requested and received a change in emergency approval from the FDA to specify that the Covid-19 vaccine bottles contain six doses instead of five after pharmacists determined that it had a bonus dose the correct syringes could be extracted. Pfizer then said it would ship fewer vials to the US, but the same number of doses specified in its contracts.

Moderna vials have also been found to contain a bonus dose, but a policy change is being sought to add volume to the vials.

The bottleneck is not the vials themselves, but the manufacturing capacity to fill the vials. The manufacturing filling / finishing process must be performed under aseptic conditions to ensure contamination does not occur and the capacity is high.

Companies have begun to form manufacturing partnerships that focus on this step in the process to increase production. Novartis announced on Friday that it has signed an initial vial fill agreement for BioNTech, Pfizer’s partner in Europe, for the Covid-19 vaccine.

“We expect this to be the first in a series of such agreements,” said Steffen Lang, head of technical operations at Novartis.

Categories
World News

Dow futures prolong losses after J&J says vaccine much less efficient in opposition to some Covid variants

Dow futures extend losses after J&J says vaccine less effective against some Covid variants

U.S. stock futures were significantly lower in early Friday trading after Johnson & Johnson said its one-off coronavirus vaccine showed less effectiveness in some regions.

The average Dow Jones Industrial futures lost 160 points, or 0.5%. S&P 500 futures lost 0.3%. Nasdaq 100 futures were down 1.5%.

Futures accelerated losses after JNJ said its single-dose vaccine had shown an overall 66% effectiveness in protecting against Covid-19. The vaccine was 72% effective in the US, 66% in Latin America, and 57% in South Africa at four weeks. The vaccine provided full protection against hospital stays related to Covid. JNJ’s shares fell 3.7% in the pre-market.

Stocks had rebounded to hit record highs in hopes that vaccines against Covid would be effective to allow for a smooth economic reopening before the end of the year. New mutations that are more resistant to vaccines could improve the bright outlook for investors.

Increased speculative trading by private investors also continued to worry the market. GameStop’s shares doubled in premarket trading after Robinhood announced it would restrict purchases of the stock and other heavily shortened names after restricting access the previous day. Robinhood raised more than $ 1 billion overnight from its existing investors and also used the banks’ credit lines to ensure that the capital was in place to start trading the volatile stocks again.

Investors are concerned that if GameStop continues to rise in such volatility, it could penetrate financial markets and cause losses at brokers like Robinhood and force hedge funds that bet against the stock to sell other stocks to raise cash.

There are also fears that the GameStop mania is a sign of a bigger bubble in the market, and that its dissolution could also create turmoil and hit retail investors hard. Several e-brokers took steps Thursday to curb intentional buying of highly speculative names. A number of lawmakers also called for an investigation into the chaotic trade.

“Between calling for hearings and reports in Washington, Robinhood was forced to not only draw on its credit lines but also raise $ 1 billion from existing investors. The whole situation continues to undermine market confidence,” said Adam Crisafulli, founder of Vital Knowledge, note in a Friday.

It’s been a volatile week on Wall Street. The Dow lost more than 600 points on Wednesday and suffered its worst sell-off in three months. Then the blue chip benchmark rallied 300 points on Thursday amid a broad market rally. All three major averages have lost at least 1% this week.

The market also saw its highest trading volume in years as the mania heated up. On Wednesday, the total market volume reached more than 23.7 billion shares, surpassing the level at the height of the financial crisis in 2008. On Thursday, there was also extremely strong trading with more than 19 billion shares that changed hands.

A wave of retailers motivated each other on the red-hot WallStreetBets Reddit forum to pile into the most hated names of hedge funds, resulting in massive short-bruising of stocks. GameStop is up more than 900% in January, while AMC Entertainment is up over 300% this month.

“This smaller capitalization rally would likely destabilize and lead to inefficiencies,” Christopher Harvey, senior equity analyst at Wells Fargo, said in a note. “Stocks are ultimately fundamentals – and reversals can be very painful, both up and down.”

However, some believe that the impact on the overall market should be limited as the retail crowd is focused on only a handful of names.

“While we believe there will be more pain, we remain optimistic that it will likely stay local,” said Maneesh Deshpande, head of equity derivatives strategy at Barclays. “Long-short hedge funds have relatively little market exposure, which indicates little impact on the overall market due to deleveraging.”

Subscribe to CNBC PRO for exclusive insights and analysis as well as live business day programs from around the world.

Categories
Health

Serving to a Teen Who Is Indignant About Home Guidelines on Covid

Helping a Teen Who Is Angry About House Rules on Covid

Our adolescence columnist, psychologist Lisa Damour, answers a reader’s question. The question has been processed.

[To submit a question, email AskDrDamour@nytimes.com.]

Q. We have a very difficult time with our 15 year old grandson who lives with us. He finally made friends after fighting socially and wanting to hang out with them, but they don’t have social distance and don’t wear masks. Some of their families don’t really believe in this pandemic. It’s an absolute mess in our house because he’s struggling to be able to do things. He says he’s sick of Covid because while he stays most of his friends don’t and go about their lives like nothing has changed. He’s angry and depressed and we don’t know what to do.

A. You and your grandson find yourself in a heartbreaking situation for which there are no complete or satisfactory solutions. I can’t tell you how much I wish it wasn’t true. First of all, I want to acknowledge the painful reality of the circumstances you described.

Even if there are no perfect remedies, the situation can possibly be improved at least a little. First, note that you face two different, albeit related, challenges. One of them is that the pandemic has uprooted your grandson’s thriving social life. The other is that his perfectly legitimate need to stop being in touch with his new friends disrupted his relationships at home. On the first front, providing your grandson with more social opportunities than you already have can be difficult. On the second side, however, there may be ways to reconnect with your isolated teen who is now more in need of loving support than ever.

Empathy, empathy, empathy is the starting point. The situation he is in is miserable and not of his creation. It may be true that he is playing off and upset everyone around him, and that many other young people are in a similar situation, and that we are starting to catch a glimpse of the light at the end of the tunnel. Try not to let these factors affect your compassion for your grandson. The adjustments we require of teens, both in terms of the way they lead their social lives and in terms of learning, are almost all the fun for teens and have been in place for almost a year. No compassion for that is too much.

Without any further agenda, convey the message to your grandson that you are very sorry that the pandemic has devastated his social life. Affectionately communicate that you understand how painful it must be to know that your friends will get together without him. Let him know that you cannot believe the pandemic has lasted this long (roughly a tenth of the life he is likely to remember) and that you understand that family support, especially for teenagers, cannot make up for the loss of contact Friends.

Compassion won’t change your dire circumstances, but it can still help alleviate your emotional suffering. Feeling alone with mental pain is far worse than believing that your plight is seen and acknowledged. So do everything you can to show your grandson that you are completely on his team.

Updated

Jan. 29, 2021, 6:05 p.m. ET

There’s another point of view that can help you build a better relationship with your grandson: Realize that he may be engaged in a persistent internal battle – between wanting to see his friends and knowing that their way of connecting to tie, does not exist. t sure – into an external fight between him and you.

It is by no means uncommon for teenagers to turn annoying personal dilemmas into fragile family struggles. Imagine a (post-pandemic) teenager who both wants to go to a concert and is also irritated by its sketchy venue. She might seek relief in recruiting her parents to take up one side of the battle. Voting that fight would be as simple as wholeheartedly lobbying to go to the concert while rolling her eyes when her people ask reasonable safety questions.

Try to free your grandson from this instinctive approach by articulating his dilemma warmly and compassionately. “It’s really frustrating,” you might say, “that your friends do things in a way that you can’t see for sure. I understand why you are so upset. “This could open the door for him to welcome you as a strategic ally.” We will do everything we can to help you see your friends safely. Can you go bike rides together or throw a ball outside? Guilt if you want to record the need to be outdoors and wearing masks with us. Just let us know if you can think of anything we could do to make this work. “

It is of course possible that your grandson does not like your proposal or wants to test the strength of his friendships. If so, there is still something else you can try. New research in the journal Child Development has shown that adolescents can endure pandemic conditions better when their families support their autonomy. Are there any options you can offer your grandson that were not previously given to him? Maybe you can tell him more about how or where he studies, what he does in his spare time, who controls the remote control or what else you can bring to the negotiating table. Own the limits of what you can offer. Acknowledge that choosing the dinner menu does not resolve problems with his friends. But having new freedoms at home might help him feel better enough.

Hopefully your efforts will lighten your grandson’s mood. If he remains unhappy no matter what you try, make an appointment with his doctor to have him checked for depression, which teenagers often experience as irritability rather than sadness.

You and your grandson are not alone in feeling drawn into a terrible corner by the pandemic. While we are so much beyond our control, we shouldn’t overlook the incremental ways we can comfort and support our teenagers.

This column does not constitute medical advice and does not replace professional psychological advice, diagnosis or treatment. If you have any concerns about your child’s well-being, talk to a doctor or mental health professional.

Categories
Health

New Covid variants are going to ‘hit us fairly onerous,’ says Dr. Peter Hotez

South Carolina detects first-known U.S. case

Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, says the US is “facing a tough journey” as new variants of Covid spread across the country.

“Because they are more transmissible, it means more Americans will be infected. Although the number of new cases has decreased slightly … the expectation now is that it will rise again because of these new variants.” “Hotez said in an interview on Thursday evening of” The News with Shepard Smith. “” More people will become infected, overwhelm hospital systems again, and possibly the death rate will rise, both from a combination of more new cases in general and one. ” slightly higher mortality rate, solely due to the variant by the type of variant. “

Health officials in South Carolina have confirmed two cases of the dangerous, highly communicable South African tribe of Covid. Officials said the cases appear unrelated and unrelated to a recent trip. Dr. Zeke Emanuel, a member of President Joe Biden’s Covid Advisory Board, said that is why the South African exposure is so worrying.

“This is worrying because these two people have no evidence of travel, and it means that the South African variant, which is more worrying than even the British variant, is about and in the community,” said Emanuel.

Hotez told host Shep Smith that the new strains were even more problematic because “we weren’t looking”.

“We’ve done so poorly on genome sequencing that we’re picking up these British, South African, and Brazilian variants. So we know they’re in South Carolina, but they could be elsewhere,” said the dean of the National School of Tropical Medicine on Baylor College of Medicine.

The Centers for Disease Control and Prevention warned that the British variant, also known as B117, could dominate the US by spring. Hotez said the key to protecting the population is to vaccinate people faster.

“The bottom line is that we need to find a way to vaccinate the American people faster than current projections,” Hotez said. “First, to reduce hospital stays and deaths, but also to stay one step ahead of these variants. If we can vaccinate three-quarters of the American population, we could potentially interrupt transmission and prevent some of these new variants from becoming dominant.”

Categories
Health

Cuomo administration underreported Covid deaths in nursing houses, report says

Cuomo administration underreported Covid deaths in nursing homes, report says

A view of a patient being rolled out of a nursing home in Flushing Queens New York USA during the coronavirus pandemic on April 22, 2020.

John Nacion | NurPhoto | Getty Images

The New York Department of Health reported Covid-19 deaths in nursing homes by up to 50%, according to a new report released Thursday by New York Attorney General Letitia James.

The 76-page report comes from a month-long investigation by the Attorney General’s office into allegations that nursing homes have failed to follow coronavirus safety protocols. Her office also investigated discrepancies between the number of deaths reported by the state Department of Health in nursing homes and the number of deaths reported by the facilities themselves.

The investigation found that the number of Covid deaths among nursing home residents in some facilities has increased by more than 50% after counting residents who died in the hospital. The official Covid-19 state death toll in nursing homes excludes patients who have died after being transported to hospital.

Democratic Governor Andrew Cuomo has been criticized for failing to disclose the total number of nursing home residents who have died from Covid-19. In her comprehensive report, James, also a Democrat, noted that “many nursing home residents in hospitals died of Covid-19 after being transferred from their nursing homes, which is not reflected in the overall data on nursing home deaths published by DOH . “

Cuomo representatives did not immediately respond to CNBC’s request to comment on the results. Representatives from the state Department of Health also did not respond to CNBC’s request for comment.

The attorney general’s findings put them directly in conflict with the governor, who often boasted of the state’s response to the coronavirus. Cuomo has also dismissed criticism of a policy by the Ministry of Health that directed nursing homes to accept residents who tested positive for the coronavirus. The governor has repeatedly defended his government’s response to the pandemic, stating that the state was poorly supported by an inept federal government that was caught by surprise by importing the virus.

In May, the federal government asked nursing homes to provide weekly data on deaths from the coronavirus, including those who died at the facility and in hospitals. However, that guideline came after the first peak of the New York outbreak, making the data available from the state nursing homes barely available. An Associated Press analysis of federal data released in August found the state could underestimate deaths by up to 65%.

James’ results are based on a survey of 62 nursing homes, or approximately 10% of nursing homes in the state. She said her law firm is continuing to investigate inconsistencies in the data reported by the Ministry of Health and the numbers reported to the Attorney General.

The investigation also found that a number of nursing homes did not adhere to “Critical Infection Control Guidelines”; B. Failing to isolate residents who test positive for the virus.

“As the pandemic and our investigation continue, it is imperative that we understand why New York nursing home residents have suffered needlessly so alarmingly,” James said in a statement. “While we cannot bring back the people we lost to this crisis, this report aims to provide transparency the public deserves and encourage increased action to protect our most vulnerable residents.”

Categories
Health

U.S. experiences document variety of Covid deaths in January

U.S. reports record number of Covid deaths in January

Lila Blanks holds the coffin of her husband Gregory Blanks, 50, who has died of coronavirus disease (COVID-19), before his funeral in San Felipe, Texas, USA, on January 26, 2021.

Callaghan O’Hare | Reuters

The United States started 2021 with the deadliest month of the coronavirus pandemic yet.

The January death toll has already surpassed the previous record number of deaths in December, according to Johns Hopkins University, when over 77,400 people died of Covid-19 in the United States. According to the data, the pandemic has killed more than 79,200 people so far this month.

In the past seven days, the country has reported an average of more than 3,300 deaths from Covid-19 per day, according to Hopkins, up 12% from a week ago.

There is hope that the death toll will slow in the coming weeks. The number of new cases reported daily in the US, which epidemiologists use as a leading indicator of whether the outbreak is increasing or decreasing, has steadily declined in recent days as an increase from interstate travel and holiday celebrations appears to be easing.

The U.S. reported about 146,600 new cases Tuesday, bringing the Hopkins average from seven days to just over 166,300 and about 17% from a week, according to Hopkins.

The number of people currently hospitalized with Covid-19 in the United States is also falling, but remains worryingly high. More than 108,900 people were hospitalized with the disease on Tuesday, according to data from the COVID Tracking Project, which was set up by journalists in the Atlantic. That’s not the high point of the more than 130,000 hospital patients reported earlier this month.

However, the potential spread of new, contagious strains of virus in the US, coupled with a slower-than-expected vaccine adoption, threatens to reverse advances in combating the outbreak.

First discovered in the United Kingdom and become the dominant strain there, the B.1.1.7 strain of the virus has been found in a number of states in the United States. Epidemiologists say the strain appears to be spreading more easily, and British officials have said it could also be more deadly.

As of Monday, the Centers for Disease Control and Prevention said 293 cases related to this strain of the virus had been found in the United States, mainly in Florida and California.

Earlier this week, the Minnesota Department of Health confirmed the first known US case of another strain of the virus that was originally discovered in Brazil. Another so-called worrying variant, named 501Y.V2 or B.1.351 depending on the epidemiologist, was first discovered in South Africa and worries scientists, since vaccines and drugs against this strain seem to be less effective. No cases related to this strain have been discovered in the United States

To curb the spread of the virus and especially the importation of new strains, President Joe Biden banned most non-US citizens traveling from South Africa from entering the US earlier this week, and increased travel restrictions for Europe, the UK and Brazil.

The president painted a dire picture of the outbreak, saying on Monday that the US “will see between 600,000 and 660,000 deaths before we start turning the corner on a large scale”.

While Biden urges people to wear masks and follow public health measures like social distancing, he is working to push the adoption of the Covid vaccines and blaming the Trump administration for the initially slow pace. On Monday, he said the US could surpass 1.5 million vaccinations per day, compared to its previous target of 1 million per day, which the last administration had almost reached.

“Time is of the essence,” he said earlier this week. “We are trying to get at least 100 million vaccinations in 100 days and move in the next 100 days where we are way beyond that to get to the point where we can get herd immunity in a country.” of over 300 million people. “

On Tuesday, he said the government was working to buy an additional 200 million doses of Pfizer’s and Moderna’s vaccines, increasing US supply from 400 million doses to 600 million, although that won’t speed up the pace of vaccinations anytime soon. He also said the administration will increase the number of cans shipped to states each week by about 20%. Some states have stated that they are able to vaccinate more people but are limited by the supply.

Categories
Business

New York’s Cuomo lifts Covid restrictions however worries about new strains

NY Gov. Cuomo briefs the press on Covid pandemic as state distributes vaccines

New York Governor Andrew Cuomo wears a protective face mask as he approaches during a daily briefing following the coronavirus disease (COVID-19) outbreak in Manhattan in New York City, New York, the United States, on July 13, 2020 Word comes.

Facebook Facebook Logo Log in to Facebook to connect with Mike Segar Reuters

New York has seen its worst coronavirus outbreak after the holidays and will begin lifting restrictions on much of the state, but more contagious strains of the virus that have recently surfaced could stifle that progress, Governor Andrew Cuomo said on Wednesday.

Triggered by dinner with family and friends, the vacation spike appears to have peaked on January 4 in New York when the positivity rate, or the percentage of Covid tests that came back positive, hit around 8% across the state. That number has since dropped to roughly 5.6%, Cuomo said.

“I think at this point it’s safe to say that the vacation rush was expected, the vacation rush actually happened, but the vacation rush is over,” Cuomo said during a press conference in Albany.

The Democratic governor said the state will lift restrictions on gatherings and some non-essential business in most of the state – except in parts of the greater New York City area, including Washington Heights, the Bronx and Queens, and the greater Newburgh area in the hinterland.

These areas are still being viewed as “yellow zones” as part of New York’s micro-cluster strategy to target economic restrictions on specific areas where the virus is more prevalent. New York will lift restrictions on any remaining orange and yellow zones, removing tighter restrictions on indoor dining, collecting sizes, and businesses like gyms, barbershops, and hair salons.

Existing Zones in New York State

Source: New York State

As part of the state’s reopening strategy, New York restaurants are only allowed to dine al fresco or take out and delivery. Cuomo said he plans to meet with Mayor Bill de Blasio and health officials to discuss how to reopen indoor dining in the city and that he will provide more details later this week.

However, concerns remain that new, more contagious variants of the coronavirus, first identified in the UK, South Africa and Brazil, could question and threaten the state’s ability to treat an influx of Covid-19 patients.

“The new strains are a real problem and the Covid threat is not over yet,” said Cuomo.

A recent study by the Centers for Disease Control and Prevention estimates that variant B.1.1.7 found in the UK could become the dominant strain of the virus by March. So far, New York has identified 22 Covid-19 cases with the mutated strain, according to recent data from the CDC.

However, the federal agency warns that the number is based on sampling and is not the total number of B.1.1.7 cases that may be floating around.

Cuomo said increasing the number of available hospital beds was not the primary concern of the state but rather the lack of medical staff to treat a wave of new patients if they contracted the virus themselves.

“Yeah, it’s scary, and all I can tell you is we’ll see it and adjust,” said Cuomo. “If it changes, we will change.”

Categories
Health

3M CEO Mike Roman expects robust Covid demand for N95s all through 2021

3M CEO Mike Roman expects strong Covid demand for N95s throughout 2021

Mike Roman, chairman and CEO of 3M, said Tuesday the industrial giant expects demand for its N95 respirators to be robust through 2021, even as Covid vaccine delivery raises hopes that the intensity the pandemic is gradually subsiding.

The medical masks are considered the best option to protect against infection and have been in need – and sometimes in shortage – throughout the health crisis. 3M, based in St. Paul, Minnesota, began increasing production of N95 about a year ago when the novel coronavirus, which first appeared in China in late 2019, was a global concern.

“We expect the demand for our N95 respirators to be strong later this year,” Roman said Tuesday on CNBC’s Squawk on the Street. “We see the demand and needs of healthcare workers and first responders at the forefront. That is still our priority. We are focused on serving their demand as well as some critical industries that need this N95 protection.”

Roman’s comments came after 3M reported better-than-expected fourth-quarter results. Sales of $ 8.58 billion beat Wall Street’s projections of $ 8.4 billion, while earnings per share of $ 2.38 were 23 cents above estimates.

For the full year, 3M saw 12.3% sales growth in healthcare, which includes respirators and products such as hand sanitizers. The company’s total revenue of $ 32.2 billion in 2020 increased 0.1% from 2019.

3M distributed 2 billion respirators worldwide last year.

In addition to the short-term need for masks, Roman said another factor likely to fuel continued demand is governments looking to replenish their stocks. For example, the Associated Press reported in August that the US government’s national supply of personal protective equipment for health workers was nearly depleted at the time.

3M’s shares rose about 3% to nearly $ 176 apiece on Tuesday – basically unchanged since the start of the year and down slightly over the past 12 months.